Renalytix plc Quarterly Deferred Tax Assets, Operating Loss Carryforwards in USD from Q2 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
Summary
Renalytix plc quarterly Deferred Tax Assets, Operating Loss Carryforwards history and growth rate from Q2 2018 to Q2 2024.
  • Renalytix plc Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending June 30, 2024 was $46M, a 21.8% increase year-over-year.
Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (USD)
Deferred Tax Assets, Operating Loss Carryforwards, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $46M +$8.22M +21.8% Jun 30, 2024 10-K 2024-09-30
Q2 2023 $37.7M +$10.5M +38.7% Jun 30, 2023 10-K 2024-09-30
Q2 2022 $27.2M +$13.7M +102% Jun 30, 2022 10-K 2023-09-28
Q2 2021 $13.5M +$9.2M +214% Jun 30, 2021 20-F 2022-10-31
Q2 2020 $4.3M +$2.46M +134% Jun 30, 2020 20-F 2022-10-31
Q2 2019 $1.83M +$1.67M +1024% Jun 30, 2019 20-F/A 2022-08-01
Q2 2018 $163K Jun 30, 2018 20-F/A 2020-11-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.